Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Did You See ResMed’s (ASX:RMD) Latest Takeover?

This week, ResMed Inc. (ASX:RMD) announced it will be acquiring MatrixCare for US$750 million.

This week ResMed Inc. (ASX: RMD) announced it will be acquiring MatrixCare for US$750 million.

ResMed is one of the world’s largest businesses focused on treating sleep-related breathing disorders such as sleep apnea.

The MatrixCare US$750 million acquisition

MatrixCare is US-based long-term post-acute care software business. It serves more than 15,000 providers in skilled nursing, life plan communities, senior living and private duty.

The MatrixCare software has a number of uses including point of care, lead and referral management, claims processing, payroll and nutritional management, as well as other users.

MatrixCare’s estimated revenue for 2018 is US$122 million, with EBITDA of around $30 million (click here to learn what EBITDA means). ResMed management expect it to increase its gross margin and profit per share (EPS) as soon as the deal is complete.

ResMed will fund the US$750 million acquisition mostly with debt and it’s expected to be completed by ResMed’s 2019 half year result, which should mean by the end of December 2018.

Mick Farrell, CEO of ResMed, believes this is a step towards achieving a market-leading position. He said, “ResMed is the world’s leading tech-driven medical device company and is well positioned to be the leading out-of-hospital software provider in the market.”

ResMed now owns a number of software services including Brightree, HEALTHCAREfirst and — soon –MatrixCare. The company recently reported its net profit grew by 23% in the first quarter of its 2019 financial year.

The ResMed share price is up 13.7% over the past six months according to Google Finance.

Read Next: 3 Proven ASX Shares

The Rask Group Pty Ltd has issued its latest investing research report on 3 proven ASX dividend + growth sharesClick here to access the free report. No credit card or payment required. (sponsored)

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content